[Photo / IC]

The best drug regulator of China granted the approval of the conditional market to two Vaccines Covid-19 on Thursday, adding arsenal growth against the disease.

One of the newly approved vaccines, developed jointly by the Biological of Tianjin kangaroos based in Tianjin and the Academy of Military Sciences, is the first COVID vaccine adenovirus vector to obtain authorization in China , according to the National Administration of Medical Products a statement launched on its website.

The AD5-NCOV vaccine is also the first single-dose candidate in the country, informing an efficiency rate of 65.28 percent to prevent all symptomatic cases and 90.07 percent when preventing serious infections.

The other vaccine obtained by the approval on Thursday is developed by the Biological Products Institute of State-owned Wuhan of SinoFarm in Wuhan, Province of Hubei. The inactivated two-dose vaccine reports a general effectiveness rate of 72.51 percent.

China approved its first VACCOTO COVID-19, created by the Beijing Institute of Biological Products of SinoFarm, at the end of December and the second vaccine from the Beijing Biotechnology, earlier this month. Both require two shots to complete the immunization.

Beijing  Tianjin 

Image of How to find a teaching job in Universities in China
Rate and Comment
Image of Longer vaccine interval may be more effective against Omicron subvariants: study
Longer vaccine interval may be more effective against Omicron subvariants: study

Beijing, July 12 (Xinhua): In the absence of specific omicrona vaccines, which extends the vaccination period between the doses can contribute to sto

Read more →




Already have an account? Login here

contact us


Add Job Alert